Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 43,278 shares at $16.76 ($726K) on 2017-04-26, disclosed to the SEC on 2017-04-28.
Open-market sale of $726k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.76 | 3,200 | $54K | 7.4% |
| 2 | $16.76 | 3,200 | $54K | 7.4% |
| 3 | $16.84 | 13,527 | $228K | 31.4% |
| 4 | $16.84 | 13,527 | $228K | 31.4% |
| 5 | $16.62 | 4,912 | $82K | 11.2% |
| 6 | $16.62 | 4,912 |
| $82K |
| 11.2% |
| Total | $16.78 avg | 43,278 | $726K | 100% |
| Filing → |
| CRSP | SELL | 2018-01-02 | $840K | — | Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |